A phase III randomized open-label comparative study of standard whole brain radiation therapy with or without RSR13 [efaproxiral] in patients with brain metastases.
Phase of Trial: Phase III
Latest Information Update: 09 May 2013
At a glance
- Drugs Efaproxiral (Primary)
- Indications Cancer metastases
- Focus Registrational; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 15 Nov 2007 Status changed from in progress to completed.
- 28 Sep 2005 New trial record.